Co-infections

Joint report with the WHO Regional Office for Europe on HIV/AIDS surveillance – 2021 data

shabnam.abdullayeva_2293 — Fri, 23 Dec 2022 11:32:17 +0000

Joint report with the WHO Regional Office for Europe on HIV/AIDS surveillance – 2021 data shabnam.abdullayeva_2293 Fri, 12/23/2022 - 11:32

HIV transmission remains a major public health concern and affects more than 2.3 million people in the WHO European Region, particularly in the Eastern part of the Region. This report is the latest in a series published jointly by the European Centre for Disease Prevention and Control (ECDC) and the WHO Regional Office for Europe that has been reporting data on HIV and AIDS in the WHO European Region and in the European Union and European Economic Area (EU/EEA) since 2007. It finds that while epidemic patterns and trends vary widely across European countries, nearly 107 000 people were diagnosed with HIV in the European Region in 2022, including around 17 000 in the EU/EEA.

Report ECDC, WHO

Is the material copyright protected?

Yes

Website

https://www.ecdc.europa.eu/en/publications-data/hiv-aids-joint-report-surveillance-2021-data

(Undocumented) Migrants

Gay men and other MSM

Heterosexuals

Injecting drug users (IDUs)

LGBTI

Men having sex with men (MSM)

People living with HIV (PLHIV)

Sex workers

Women

WHO European region

Co-infections

Epidemiology

Gender

Prevention

Sexual and reproductive health

Global Fund Results Report 2022

shabnam.abdullayeva_2293 — Wed, 05 Oct 2022 16:15:18 +0000

Global Fund Results Report 2022 shabnam.abdullayeva_2293 Wed, 10/05/2022 - 16:15

Global Fund Results Report 2022 details how the partnership played a critical role in supporting countries and communities to respond to the pandemic and continue the progress in the fight against HIV, TB and malaria.

The coverage of treatment and prevention interventions for HIV, TB and malaria in countries where the Global Fund invests has increased rapidly since we were created in 2002. However, while the growth in HIV coverage levels remains steady, TB and malaria coverage have both declined in recent years.

Report

Year

2022 Global Fund

Is the material copyright protected?

I don't know

corporate_2022resultsreport_report_en (1).pdf

General public

People living with HIV (PLHIV)

Global

Co-infections

Inequalities in health

Testing and counselling

Treatment

Tubercolosis

Viral hepatitis

Increase in severe acute hepatitis cases of unknown aetiology in children

shabnam.abdullayeva_2293 — Wed, 27 Jul 2022 12:40:47 +0000

Increase in severe acute hepatitis cases of unknown aetiology in children shabnam.abdullayeva_2293 Wed, 07/27/2022 - 12:40

As of 20 April 2022, 111 cases had been reported from the UK, and as of 27 April 2022 approximately 55 probable and confirmed cases have been reported from 12 EU/EEA countries. An additional 12 cases have been reported from the United States (US), 12 from Israel, and one from Japan. The clinical picture is of severe acute hepatitis requiring hospitalisation with jaundice and markedly elevated liver transaminases. In most cases to date, the onset of jaundice was preceded by a gastrointestinal illness with vomiting, diarrhoea, and nausea. Information on the outcome of the cases is still being collected. So far, most patients for whom information is available have recovered, but a number have progressed to acute liver failure and required liver transplantation.

Report

Year

2022 ECDC

Is the material copyright protected?

I don't know

Website

https://www.ecdc.europa.eu/en/publications-data/increase-severe-acute-hepatitis-cases-unknown-aetiology-children

RRA-20220420-218-erratum.pdf

General public

Youth

WHO European region

Co-infections

Epidemiology

Viral hepatitis

Mothers and babies can’t wait: A call for action to end mother-to-child transmission of hepatitis

shabnam.abdullayeva_2293 — Wed, 27 Jul 2022 12:25:31 +0000

Mothers and babies can’t wait: A call for action to end mother-to-child transmission of hepatitis shabnam.abdullayeva_2293 Wed, 07/27/2022 - 12:25

As the World Health Organization (WHO) works toward its goal to eliminate hepatitis B by 2030, the quest to halt hepatitis B mother-to-child transmission has never been more urgent.

Many of the key issues brought into focus over recent years have combined to delay progress of the prevention of mother-to-child transmission (PMTCT) of hepatitis B. Such issues include racial inequality, discrimination against women, and gross inequalities of healthcare access across the globe.

If we are to reach the 2030 hepatitis B elimination goals, we must address the systemic barriers to PMTCT around the world. Caring for women means providing antenatal care, sexual and reproductive health promotion, and access to essential and lifesaving care. Providing this to mothers, their new-borns and their children is vital for ensuring that hepatitis B is adequately addressed.

Other

Year

2022 World Hepatitis Alliance

Is the material copyright protected?

I don't know

Website

https://www.worldhepatitisalliance.org/pmtct-report/

PMTCT-White-Paper-spreads.pdf

General public

Health care professionals

Women

Youth

Global

Co-infections

Treatment

Viral hepatitis

The Impact of Stigma and Discrimination Affecting People with Hepatitis B

shabnam.abdullayeva_2293 — Tue, 05 Jul 2022 12:11:38 +0000

The Impact of Stigma and Discrimination Affecting People with Hepatitis B shabnam.abdullayeva_2293 Tue, 07/05/2022 - 12:11

This report highlights the human experiences of stigma and discrimination related to hepatitis B, demonstrating the impact that living with the virus can have on mental health, quality of life, individual freedoms and human rights. We focus on the work of people trying to challenge this stigma and discriminations and describe the support they need to be successful.

Report

Year

2022 World Hepatitis Alliance

Is the material copyright protected?

I don't know

Website

https://www.worldhepatitisalliance.org/stigma/

WHA-Report-2021-Final.pdf

General public

Global

Co-infections

Stigma and discrimination

Viral hepatitis

Civil Society Monitoring of Harm Reduction in Europe 2021

shabnam.abdullayeva_2293 — Tue, 05 Jul 2022 11:44:05 +0000

Civil Society Monitoring of Harm Reduction in Europe 2021 shabnam.abdullayeva_2293 Tue, 07/05/2022 - 11:44

Correlation – European Harm Reduction Network launched its Civil Society Monitoring of Harm Reduction in Europe in 2021.

The main aim and purpose of C-EHRN monitoring activities is to improve knowledge and information and complement existing data and monitoring efforts in Europe in specific areas of harm reduction based on the perspective of civil society organisations (CSOs). The data collection helps to assess the implementation of certain drug and health policies at national and local level and supports the advocacy efforts at European and EU Member State level.

Report

Year

2022 Correlation European Harm Reduction Network

Is the material copyright protected?

I don't know

Website

https://www.correlation-net.org/monitoring/

MONITORING-OF-HARM-REDUCTION-IN-EUROPE-2021_web.pdf

Gay men and other MSM

Injecting drug users (IDUs)

LGBTI

Migrants

NGOs

People who use drugs (PUD)

Sex workers

Women

Central Europe

Eastern Europe

Northern Europe

Southern Europe

Western Europe

Advocacy

Co-infections

Harm reduction

Monitoring and Evaluation

Policy

100 Days of War. Alliance for Public Health: Response to War Challenges

shabnam.abdullayeva_2293 — Fri, 17 Jun 2022 15:18:33 +0000

100 Days of War. Alliance for Public Health: Response to War Challenges shabnam.abdullayeva_2293 Fri, 06/17/2022 - 15:18

With this document Alliance for Public Health presents presents the health challenges in Ukraine, since the start of the war by Russia, including the impact on HIV and TB programs. However, the document also includes the modified health response by the Alliance for Public Health in the face of these challenges.

Other

Year

2022 Alliance for Public Health

Is the material copyright protected?

I don't know

Website

https://aph.org.ua/en/news/100-days/

APH-100-DAYS-OF-WAR-2.pdf

(Undocumented) Migrants

General public

NGOs

People living with HIV (PLHIV)

Refugees

Eastern Europe

Co-infections

Human rights

Resource mobilisation

Tubercolosis

Viral hepatitis

Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine

shabnam.abdullayeva_2293 — Fri, 17 Jun 2022 15:11:33 +0000

Testing for tuberculosis infection and screening for tuberculosis disease among refugees arriving in European countries from Ukraine shabnam.abdullayeva_2293 Fri, 06/17/2022 - 15:11

This document provides an overview of public health guidance on testing for TB infection, TB preventive treatment and screening for TB disease, in the context of the mass influx of people arriving in European countries from Ukraine.

Guidelines

Year

2022 ECDC, WHO

Is the material copyright protected?

I don't know

ECDC-WHO-information-note-TB-testing-and-screening.pdf

(Undocumented) Migrants

Central Europe

Eastern Europe

Northern Europe

Southern Europe

Western Europe

Co-infections

Testing and counselling

Tubercolosis

Addressing the health challenges in immigration detention, and alternatives to detention: a country implementation guide

admin — Tue, 10 May 2022 16:22:00 +0000

Addressing the health challenges in immigration detention, and alternatives to detention: a country implementation guide admin Tue, 05/10/2022 - 16:22

This country implementation guide outlines current evidence, knowledge and best practices relating to the health and health challenges of refugees and migrants in immigration detention, as well as alternatives to detention.

It highlights key principles and international commitments, summarizes the current status and health challenges and provides practical considerations for addressing the health challenges of refugees and migrants in immigration detention, as well as the implementation of alternatives to detention.

Specific areas for intervention include providing comprehensive training for staff, ensuring safeguards, providing psychological support and providing tools to prevent the spread of communicable diseases.

The guide also promotes engagement-based alternatives to detention. While the main intended audience is policy-makers across sectors at local, national and regional levels, the guide is also of value for health planners, relevant ministries, international organizations, management of immigration detention facilities and their staff, and researchers.

Report

Year

2022 WHO

Is the material copyright protected?

I don't know

Website

https://www.euro.who.int/en/health-topics/health-determinants/migration-and-health/publications/2022/addressing-the-health-challenges-in-immigration-detention,-and-alternatives-to-detention-a-country-implementation-guide-2022

AAE Strategic Plan 2022-2026_english.pdf

(Undocumented) Migrants

Migrants

WHO European region

Co-infections

Human rights

Inequalities in health

Migration

Social issues

Drug-related infectious diseases: health and social responses

shabnam.abdullayeva_2293 — Sat, 11 Dec 2021 23:06:00 +0000

Drug-related infectious diseases: health and social responses shabnam.abdullayeva_2293 Sat, 12/11/2021 - 23:06

This miniguide on responding to drug-related infectious diseases is one of a larger set, which together comprise Health and social responses to drug problems: a European guide 2021. It provides an overview of the most important aspects to consider when planning or delivering health and social responses to drug-related infectious diseases, and reviews the availability and effectiveness of the responses. It also considers implications for policy and practice.

Report European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)

Is the material copyright protected?

I don't know

Website

https://www.emcdda.europa.eu/publications/mini-guides/drug-related-infectious-diseases-health-and-social-responses_en#section2

www.emcdda.europa.eu%20-%20Drug-related%20infectious%20diseases%20health%20and%20social%20responses%20-%202021-12-17.pdf

General public

Injecting drug users (IDUs)

Central Europe

Southern Europe

Western Europe

Co-infections

Epidemiology

Harm reduction

Testing and counselling

Tubercolosis

Viral hepatitis